These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8162530)

  • 1. How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
    Connolly S
    Can J Cardiol; 1994 Apr; 10(3):330. PubMed ID: 8162530
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
    Michel B; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias.
    Theilen EO; Wilson WR
    Med Clin North Am; 1968 Sep; 52(5):1017-29. PubMed ID: 4386418
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
    Teo KK
    Can J Cardiol; 1994 Apr; 10(3):333-8. PubMed ID: 8162531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
    Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P
    Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation in acute myocardial infarction.
    Stannard M; Sloman JG
    Med J Aust; 1967 Jun; 1(25):1250-2. PubMed ID: 6027868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of ajmalin (gylurritmal) in the treatment of a paroxysmal auricular fibrillation lasting for 3 weeks in a case of W.P.W].
    Duclós F
    Rev Esp Cardiol; 1969; 22(2):240-54. PubMed ID: 5801961
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
    Ozaydín M; Varol E; Dogan A; Aslan SM; Altínbas A
    Minerva Cardioangiol; 2007 Jun; 55(3):427. PubMed ID: 17534262
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial fibrillation triggered by postinfarction ventricular premature beats in a patient with Wolff-Parkinson-White syndrome.
    Peinado R; Merino JL; Gnoatto M; Arias MA
    Europace; 2005 May; 7(3):221-4. PubMed ID: 15878558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe arrhythmia in Wolff-Parkinson-White syndrome].
    Márquez-Montes J; Esteve Alderete JJ; Rufilanchas JJ; Benezet JM; Lorenzo AC; Lezáun R; de Artaza M
    Rev Esp Cardiol; 1980; 33(3):217-25. PubMed ID: 7422987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation].
    Szmydt W; Brodzińska K; Luczak J
    Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tactics of treatment of patients with arrhythmia].
    Glezer MG; Orlov LL
    Klin Med (Mosk); 1995; 73(4):13-7. PubMed ID: 7474808
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
    Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation and Wolff-Parkinson-White syndrome. The hidden danger of manifested pathways].
    Cruz Filho FE
    Arq Bras Cardiol; 1995 Feb; 64(2):97-100. PubMed ID: 7575169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should prophylactic antiarrhythmic drug therapy be employed in acute myocardial infarction?
    Berte LE; Harrison DC
    Cardiovasc Clin; 1983; 13(1):173-81. PubMed ID: 6336666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
    Bodalski R; Maryniak A; Walczak F; Szumowski L; Jedynak Z
    Kardiol Pol; 2008 Dec; 66(12):1346-9. PubMed ID: 19169985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utilization of anti-arrhythmic drugs].
    Perrenoud JJ
    Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of the spectrum of the anti-arrhythmic effect of N-propyl-ajmalin bromide].
    Gendenimein EI
    Biull Eksp Biol Med; 1969 Apr; 67(4):60-3. PubMed ID: 5785263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.